Galaxy Gets $18M To Advance Centauri Pulsed Field Ablation System
Executive Summary
ATP, a venture capital firm focused on life sciences, is providing the series A round to help Galaxy complete European and Canadian trials of its Centauri pulsed field ablation technology to treat atrial fibrillation.